AAO-HNSF Clinical Practice Guideline Development
Public Comment – Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (BPPV)
Monday, August 22 - Monday, September 5, 2016
A draft of the newly updated Clinical Practice Guideline (CPG): Benign Paroxysmal Positional Vertigo (BPPV) is now available for public comment. The comment period will run from noon ET on Monday, August 22 through 11:00 PM ET, Monday, September 5, 2016.
During this time, members of the public are encouraged to review the guideline and provide comments. While the goal of this phase is to obtain public comment, we also encourage other stakeholders to participate, if they so desire. The purpose of the comment period is to ensure that all stakeholders have an opportunity to review the guideline recommendations, action statement profiles, and supporting text prior to publication.
Please remember that this guideline is intended for all clinicians who are likely to diagnose and manage patients with BPPV, and applies to any setting in which BPPV would be identified, monitored, or managed. The target patient is aged 18 years or older with a suspected or potential diagnosis of BPPV.
We ask non-healthcare professionals, specifically, to pay close attention to the the evidence profile of each action statement. Action statement profiles contain information regarding the role of patient preferences, benefit/harm assessment, and intentional vagueness, which may be most relevant to members of the public.
To participate in the public comment, users must agree not
to distribute or share the draft guideline with any other individuals or organizations prior to the official publication of the guideline, and must disclose any conflicts of interest. Following conflict of interest disclosure, a PDF of the guideline document will then become available, and users will receive a link to the comment page.